• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON & CO (FRANKLIN LAKES) BD VACUTAINER® CPT¿ CELL PREPARATION TUBE WITH SODIUM CITRATE; LYMPHOCYTE SEPARATION MEDIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON & CO (FRANKLIN LAKES) BD VACUTAINER® CPT¿ CELL PREPARATION TUBE WITH SODIUM CITRATE; LYMPHOCYTE SEPARATION MEDIUM Back to Search Results
Catalog Number 362760
Medical Device Problem Code Device Ingredient or Reagent Problem (2910)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/26/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Investigation summary: bd received 3 photos for investigation.Upon visual evaluation of the three photos, the customer¿s reported defect was confirmed.The retained samples could not be inspected as the lot number is unknown.Complaints for sample quality are under statistical control for the month of december 2025.At this time, further testing is not indicated.The device history records could not be reviewed as the lot number is unknown.This complaint has been confirmed for the indicated failure mode: poor barrier separation based on the photos provided.No definitive root cause could be established for the reported defect.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for the identification of emerging trends.Bd quality will continue to monitor sample quality complaints.
 
Event or Problem Description
It was reported while using bd vacutainer® cpt¿ cell preparation tube with sodium citrate, an unspecified number of tubes exhibited poor barrier separation.There was no health impact or consequences reported.
 
Additional Manufacturer Narrative
D.4.Medical device expiration date: unknown.H.4.Device manufacture date: unknown.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported while using bd vacutainer® cpt¿ cell preparation tube with sodium citrate, an unspecified number of tubes exhibited poor barrier separation.There was no health impact or consequences reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VACUTAINER® CPT¿ CELL PREPARATION TUBE WITH SODIUM CITRATE
Common Device Name
LYMPHOCYTE SEPARATION MEDIUM
Manufacturer (Section D)
BECTON DICKINSON & CO (FRANKLIN LAKES)
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
Manufacturer Contact
anand singh
1 becton drive
franklin lakes, NJ 07417
2018475186
MDR Report Key24139369
Report Number1917413-2025-01777
Device Sequence Number13359047
Product Code JCF
UDI-Device Identifier30382903627609
UDI-Public(01)30382903627609
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
NA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number362760
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/26/2025
Supplement Date Received by Manufacturer01/30/2026
Initial Report FDA Received Date01/21/2026
Supplement Report FDA Received Date02/27/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-